A2A adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats

Behavioural Pharmacology

Volumn 23, Issue 5-6, 2012, Pages 567-574

  Micioni Di Bonaventura, Maria V ^a   Cifani, Carlo ^a   Lambertucci, Catia ^a   Volpini, Rosaria ^a   Cristalli, Gloria ^a   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

A2A adenosine receptor; A2A adenosine receptor agonists; binge eating; CGS 21680; food deprivation induced feeding; high palatability food intake; low palatability food intake; rat; VT 7

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR AGONIST; UNCLASSIFIED DRUG; VT 7; 2 (4 (2 CARBOXYETHYL)PHENETHYLAMINO) 5' N ETHYLCARBOXAMIDOADENOSINE; 2-(4-(2-CARBOXYETHYL)PHENETHYLAMINO)-5'-N-ETHYLCARBOXAMIDOADENOSINE; 5' N ETHYLCARBOXAMIDO 2 (2 PHENETHYLTHIO)ADENOSINE; 5'-N-ETHYLCARBOXAMIDO-2-(2-PHENETHYLTHIO)ADENOSINE; ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ANOREXIGENIC AGENT; DRUG DERIVATIVE; NERVE PROTEIN; NUCLEOSIDE; PHENETHYLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINGE EATING DISORDER; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FLUID INTAKE; FOOD INTAKE; LOCOMOTION; NONHUMAN; OBESITY; PALATABILITY; RAT; REFEEDING; STRESS; ANIMAL; ANIMAL BEHAVIOR; CALORIC INTAKE; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; FEEDING BEHAVIOR; FOOD PREFERENCE; METABOLISM; PSYCHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; APPETITE DEPRESSANTS; APPETITE REGULATION; BEHAVIOR, ANIMAL; BINGE-EATING DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENERGY INTAKE; FEEDING BEHAVIOR; FEMALE; FOOD PREFERENCES; NERVE TISSUE PROTEINS; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; SATIETY RESPONSE; THIONUCLEOSIDES;

EID: 84864880406     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283566a60     Document Type: Article

References (76)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. 4th ed. Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
2. Arbaizar B, Gó mez-Acebo I, Llorca J (2008). Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review. Gen Hosp Psychiatry 30:471-475.
3. Avena NM (2007). Examining the addictive-like properties of binge eating using an animal model of sugar dependence. Exp Clin Psychopharmacol 15: 481-491.
4. Avena NM, Rada P, Hoebel BG (2008). Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32:20-39.
5. Avena NM, Bocarsly ME, Hoebel BG, Gold MS (2011). Overlaps in the nosology of substance abuse and overeating: the translational implications of 'food addiction'. Curr Drug Abuse Rev 4:33-39.
6. Bastia E, Xu YH, Scibelli AC, Day YJ, Linden J, Chen JF, Schwarzschild MA (2005). A crucial role for forebrain adenosine A(2A) receptors in amphetamine sensitization. Neuropsychopharmacology 30:891-900.
7. Bello NT, Hajnal A (2010). Dopamine and binge eating behaviors. Pharmacol Bioichem Behav 97:25-33.
8. Bello NT, Lucas LR, Hajnal A (2002). Repeated sucrose access influences dopamine D2 receptor density in the striatum. Neuroreport 13:1575-1578.
9. Broft AI, Spanos A, Corwin RL, Mayer L, Steinglass J, Devlin MJ, et al. (2007). Baclofen for binge eating: an open-label trial. Int J Eat Disord 40:687-691.
10. Broft AI, Berner LA, Martinez D,Walsh BT (2011). Bulimia nervosa and evidence for striatal dopamine dysregulation: a conceptual review. Physiol Behav 104:122-127.
11. Brown RM, Short JL (2008). Adenosine A(2A) receptors and their role in drug addiction. J Pharm Pharmacol 60:1409-1430.
12. Brown RM, Short JL, Cowen MS, Ledent C, Lawrence AJ (2009). A differential role for the adenosine A2A receptor in opiate reinforcement vs opiate-seeking behavior. Neuropsychopharmacology 34:844-856.
13. Burnstock G (2007). Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659-797.
14. Castané A, Soria G, Ledent C, Maldonado R, Valverde O (2006). Attenuation of nicotine-induced rewarding effects in A2A knockout mice. Neuropharmacology 51:631-640.
15. Castané A, Wells L, Soria G, Hourani S, Ledent C, Kitchen I, et al. (2008). Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A(2A) receptor knockout mice. Br J Pharmacol 155:757-776.
16. Cifani C, Polidori C, Melotto S, Ciccocioppo R, Massi M (2009). Preclinical model of binge-eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate and midazolam. Psychopharmacology 204:113-125.
17. Colantuoni C, Schwenker J, McCarthy J, Rada P, Ladenheim B, Cadet JL, et al. (2001). Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 12:3549-3552.
18. Corwin R, Avena NM, Boggiano MM (2011). Feeling and reward: perspective from three rat models of binge eating. Physiol Behav 104:87-97.
19. Cottone P, Sabino V, Roberto M, Bajo M, Pockros L, Frihauf JB, et al. (2009). CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci USA 106:20016-20020.
20. Cousins MS, Atherton A, Turner L, Salamone JD (1996). Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/benefit task. Behav Brain Res 74:189-197.
21. Cousins MS, Trevitt J, Atherton A, Salamone JD (1999). Different behavioral functions of dopamine in the nucleus accumbens and ventrolateral striatum: a microdialysis and behavioral investigation. Neuroscience 91:925-934.
22. DeMet EM, Chicz-DeMet A (2002). Localization of adenosine A2A-receptors in rat brain with [3H]ZM-241385. Naunyn Schmied Arch Pharmacol 366: 478-481.
23. Di Chiara G, Bassareo V (2007). Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7:69-76.
24. Fassino S, Leombruni P, Pierò A, Abbate-Daga G, Giacomo Rovera G (2003). Mood, eating attitudes, and anger in obese women with and without binge eating disorder. J Psychosom Res 54:559-566.
25. Ferré S, von Euler G, Johansson B, Fredholm BB, Fuxe K (1991). Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88:7238-7241.
26. Ferré S, O'Connor WTO, Fuxe K, Ungerstedt U (1993). The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci 13:5402-5406.
27. Ferré S, Diamond I, Goldberg SR, Yao L, Hourani SM, Huang ZL, et al. (2007). Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol 83:332-347.
28. Ferré S, Quiroz C, Woods AS, Cunha R, Popoli P, Ciruela F, et al. (2008). An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G-protein-coupled receptors. Curr Pharm Des 14: 1468-1474.
29. Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, et al. (1992). Molecular cloning of the rat A2A adenosine receptor: selective coexpression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res 14:186-195.
30. Foulds Mathes W, Brownley KA, Mo X, Bulik CM (2009). The biology of binge eating. Appetite 52:545-553.
31. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
32. Gearhardt AN, Corbin WR, Brownell KD (2011a). Food addiction: an examination of the diagnostic criteria for dependence. J Addict Med 3:1-7.
33. Gearhardt AN, Yokum S, Orr PT, Stice E, Corbin WR, Brownell KD (2011b). Neural correlates of food addiction. Arch Gen Psychiatry 68:808-816.
34. Gold MS, Frost-Pineda K, Jacobs WS (2003). Overeating, binge eating, and eating disorders as addictions. Psychiatry Ann 33:112-116.
35. Grucza RA, Przybeck TR, Cloninger CR (2007). Prevalence and correlates of binge eating disorder in a community sample. Compr Psychiatry 48: 124-131.
36. Hagan MM,Wauford PK, Chandler PC, Jarrett LA, Rybak RJ, Blackburn K (2002). A new animal model of binge-eating: key synergistic role of past caloric restriction and stress. Physiol Behav 77:45-54.
37. Heath AC (1998). Binge-eating and bulimia: potential insights into etiology and pathophysiology through genetic epidemiologic studies. Biol Psychiatry 44:1208-1209.
38. Heimer L, Zahm DS, Alheid GF (1995). Basal ganglia. In: Paxinos G, editor. The rat nervous system. New York: Academic. pp. 579-628.
39. Hoebel BG (1985). Brain neurotransmitters in food and drug reward. Am J Clin Nutr 42 (Suppl 5):1133-1150.
40. Hudson JI, Hiripi E, HG Pope Jr., Kessler RC (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 61:348-358.
41. Ifland JR, Preuss HG, Marcus MT, Rourke KM, Taylor WC, Burau K, et al. (2009). Refined food addiction: a classic substance use disorder. Med Hypotheses 72:518-526.
42. Javaras KN, Pope HG, Lalonde JK, Roberts JL, Nillni YI, Laird NM, et al. (2008). Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry 269:266-273.
43. Johnson PM, Kenny PJ (2010). Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 13:635-641.
44. Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238.
45. Levine AS, Morley JE (1983). Effect of intraventricular adenosine on food intake in rats. Pharmacol Biochem Behav 19:23-26.
46. McGeorge AJ, Faull RLM (1989). Organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29:503-537.
47. Meyer F (2008). Alleviation of both binge eating and sexual dysfunction with naltrexone. J Clin Psychopharmacol 28:722-723.
48. Micioni Di Bonaventura MV, Cifani C, Lambertucci C, Volpini R, Cristalli G, Froldi R, Massi M (2012). Effects of A2A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats. Psychopharmacology 219: 945-957.
49. Mingote S, Pereira M, Farrar AM, McLaughlin PJ, Salamone JD (2008). Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake. Pharmacol Biochem Behav 89:345-351.
50. Morelli M, Carta AR, Jenner P (2009). Adenosine A2A receptors and Parkinson's disease. In: Wilson CN, Mustafa SJ, editors. Adenosine receptors in Health and Disease. Handbook of Experimental Pharmacology 193. Berlin Heidelberg: Springer-Verlag.
51. Naassila M, Ledent C, Daoust M (2002). Low sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J Neurosci 22:10487-10493.
52. Pelchat ML, Johnson A, Chan R, Valdez J, Ragland JD (2004). Images of desire: food-craving activation during fMRI. Neuroimagen 23:1486-1493.
53. Pritchett CE, Pardee AL, McGuirk SR, Will MJ (2010). The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake. Brain Res 1306:85-92.
54. Rosin DL, Hettinger BD, Lee A, Linden J (2003). Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function. Neurology 61:S12-S18.
55. Salamone JD, Correa M, Farrar A, Mingote SM (2007). Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191:461-482.
56. Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, et al. (2009). Differential actions of adenosine A1 and A2A antagonists on the effortrelated effects of dopamine D2 antagonism. Behav Brain Res 201:216-222.
57. Salamone JD, Correa M, Nunes EJ, Randall PA, Pardo M (2012). The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. J Exp Anal Behav 97:125-146.
58. Schiffmann SN, Jacobs O, Vanderhaeghen JJ (1991). Striatal restricted adenosine A2A receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57:1062-1071.
59. Soria G, Castané A, Berrendero F, Ledent C, Parmentier M, Maldonado R, Valverde O (2004). Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC. Eur J Neurosci 20:2203-2213.
60. Soria G, Castané A, Ledent C, Parmentier M, Maldonado R, Valverde O (2006). The lack of A2A adenosine receptors dimishes the reinforcing efficacy of cocaine. Neuropsychopharmacology 31:978-987.
61. Spangler R,Wittkowski KM, Goddard NL, Avena NM, Hoebel BG, Leibowitz SF (2004). Opiate-like effects of sugar on gene n reward areas of the rat brain. Brain Res Mol Brain Res 124:134-142.
62. Stice E, Agras WS, Telch FC, Halmi KA, Mitchell JE,Wilson T (2001). Subtyping binge eating-disordered women along dieting and negative affect dimensions. Int J Eat Disord 30:11-27.
63. Svenningson P, Le Moine C, Fisone G, Fredholm BB (1999). Distribution biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59:355-396.
64. Vengeliene V, Bilbao A, Molander A, Spanagel R (2008). Neuropharmacology of alcohol addiction. Br J Pharmacol 154:299-315.
65. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R (2012). Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci 11:1-24.
66. Volpini R, Costanzi S, Lambertucci C, Portino FR, Taffi S, Vittori S, et al. (2004). Adenosine receptor agonists: synthesis and binding affinity of 2-(aryl)alkylthioadenosine derivatives. ARKIVOC V:301-311.
67. Wager-Srdar S, Levine AS, Morley JE (1984). Food intake: opioid/purine interactions. Pharmacol Biochem Behav 21:33-38.
68. Walsh BT, Devlin MJ (1998). Eating disorders: progress and problems. Science 280:1387-1390.
69. Wang GJ, Volkow ND, Thanos PK, Fowler JS (2004). Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 23:39-53.
70. Wang GJ, Geliebter A, Volkow ND, Telang FW, Logan J, Jayne MC, et al. (2011). Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity 19:1601-1608.
71. Weerts EM, Griffiths RR (2003). The adenosine receptor antagonist CGS15943 reinstates cocaine seeking behavior and maintains self-administration in baboons. Psychopharmacology 168:155-163.
72. Wise RA (2006). Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 361:1149-1158.
73. Wolff GE, Crosby RD, Roberts JA, Wittrock DA (2000). Differences in daily stress, mood, coping, and eating behavior in binge eating and nonbinge eating college women. Addict Behav 25:205-216.
74. Yanovski SZ (2003). Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic? Int J Eat Disord 34 (Suppl):S117-S120.
75. Yao L, Fan P, Jiang Z, Mailliard WS, Gordon AS, Diamond I (2003). Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc Natl Acad Sci USA 100: 14379-14384.
76. Yao L, McFarland K, Fan P, Jiang Z, Ueda T, Diamond I (2006). Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc Natl Acad Sci USA 103:7877-7882.